4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-060788
President & CEO acquired 94,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-12-12 | Grant or award | +94,100 | 393,319 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-12-12 | Grant or award · Stock Option | +167,650 | 167,650 | D: show line 2 in the form | |||||
| ROBIN HOWARD W President & CEO | 2019-12-12 | Grant or award · Stock Option | +44,600 | 44,600 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…